Endoscopic screening for esophageal squamous cell carcinoma

Archives of Iranian Medicine

Volumn 16, Issue 6, 2013, Pages 351-357

  Roshandel, Gholamreza ^a,b   Nouroozi, Alireza ^b   Pourshams, Akram ^a   Amiriani, Taghi ^b   Semnani, Shahryar ^b   Merat, Shahin ^a   Khoshnia, Masoud ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carcinoma; Endoscopic screening; Esophageal cancer; Iran; Squamous cell carcinoma

Indexed keywords

IODINE; LUGOL;

CANCER CONTROL; CANCER GRADING; CANCER PROGNOSIS; CANCER SCREENING; CHROMOENDOSCOPY; CONFOCAL LASER MICROSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ELASTIC SCATTERING SPECTROSCOPY; ENDOCYTOSCOPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS ULCER; FLUORESCENCE IMAGING; HIGH RISK POPULATION; HUMAN; NARROW BAND IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PRIMARY PREVENTION; RETROSTERNAL PAIN; REVIEW; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; TRIMODAL IMAGING;

CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; DIAGNOSTIC IMAGING; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FLUORESCENCE; HUMANS; IODINE; IRAN;

EID: 84878839396     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008, cancer incidence and mortality worldwide: Iarc cancerbase no. 10. Lyon: International Agency for Research on Cancer; 2010. Available from: URL: http://globocan.iarc.fr (Accessed Date: 03/02/2011)
2. Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer. 2009; 101: 1-6.
3. Das A. Tumors of the esophagus. In: Feldman M, Friedman L, Brandt LJ, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, and Management. 9th ed. Philadelphia: Saunders Elsevier; 2010. 745-770.
4. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian Littoral of Iran: The Caspian Cancer Registry. Br J Cancer. 1973; 28: 197-214.
5. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer Incidence in Five Continents, vol. Viii. Lyon: IARC; 2002.
6. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001; 92: 549-555.
7. Brown LM, Devesa SS, Chow W-H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008; 100: 1184-1187.
8. Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005; 92: 151-159.
9. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F. Esophageal cancer in northeastern Iran: a review. Arch Iran Med. 2007; 10: 70-82.
10. Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffeta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran-a review. Eur J Cancer. 2009; 45: 3156-3165.
11. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat S, Nouraie S, et al. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012; 15: 196.
12. Dawsey SM, Lewin KJ, Wang GQ, Liu FS, Nieberg RK, Yu Y et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer. 1994; 74: 1686-1692.
13. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, et al. Histological precursors of oesophageal squamous cell carcinoma: Results from a 13-year prospective follow-up study in a high-risk population. Gut. 2005; 54: 187-192.
14. Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders Elsevier.2010. 842-851
15. Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009; 38: 27-57.
16. Akbari M, Malekzadeh R, Lepage P, Roquis D, Sadjadi A, Aghcheli K, et al. Mutations in Fanconi anemia genes and the risk of esophageal cancer. Hum Genet. 2011; 129: 573-582.
17. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, et al. Germline brca2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene. 2007; 27: 1290-1296.
18. Abedi-Ardekani B, Kamangar F, Hewitt SM, Hainaut P, Sotoudeh M, Abnet CC, et al. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in northeastern Iran. Gut. 2010; 59: 1178-1183.
19. Semnani S, Roshandel G, Zendehbad A, Keshtkar A, Rahimzadeh H, Abdolahi N, et al. Soils selenium level and esophageal cancer: An ecological study in a high-risk area for esophageal cancer. J Trace Elem Med Biol. 2010; 24: 174-177.
20. Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007; 165: 1424.
21. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008; 98: 1857-1863.
22. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ. 2009; 338: b929.
23. Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Roion PA. Influence of mate drinking, hot beverages, and diet on esopha geal cancer risk in South America. Int J Cancer. 2000; 88: 658-664.
24. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, et al. Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer. 2007; 121: 2753-2760.
25. Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009; 38: 978-988.
26. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3062-3068.
27. Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: Its assessment and significance. Histopathology. 2005; 47: 123-131.
28. Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis Esophagus. 1997; 10: 155-158.
29. Wang GQ. A 30-year experience on early detection and treatment of esophageal cancer in high-risk areas. Zhongguo YiXueKeXue YuanXue Bao. 2001; 23: 69-72.
30. Morimoto M, Nishiyama K, Nakamura S, Suzuki O, Kawaguchi Y, Nakajima A, et al. Significance of endoscopic screening and endoscopic resection for esophageal cancer in patients with hypopharyngeal cancer. Jpn J Clin Oncol. 2010; 40: 938-943.
31. Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, et al. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncologica. 2012; 51: 906-914.
32. Dubecz A, Gall I, Solymosi N, Schweigert M, Peters JH, Feith M, et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a seer database analysis. J Thorac Oncol. 2012; 7: 443-447.
33. Alidina A, Gaffar A, Hussain F, Islam M, Vaziri I, Burney I, et al. Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol. 2004; 15: 118-122.
34. Aghcheli K, Maijani HA, Nasrollahzadeh D, Islami F, Shakeri R Sotoudeh M, et al. Prognostic factors for esophageal squamous cell carcinoma-a population-based study in Golestan Province, Iran, a high-incidence area. PLoS ONE. 2011; 6: e22152.
35. Dong Z, Tang P, Li L, Wang G. The strategy for esophageal cancer control in high-risk areas of China. Jpn J Clin Oncol. 2002; 32: S10-S12.
36. Liu ZR, Wei WQ, Huang YQ, Qiao YL, Wu M, Dong ZW. Economic evaluation of "early detection and treatment of esophageal cancer. Ai Zheng. 2006; 25: 200-203.
37. Yang J, Wei WQ, Niu J, Liu ZC, Yang CX, Qiao YL. Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China. WorldJ Gastroenterol. 2012; 18: 2493-2501.
38. Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008; 15: 3278-3288.
39. Makuuchi H, Nomura T, Mizutani K, Shimada H, Sugeno K, Chino O, et al. Endoscopic mucosal resection for early esophageal cancer by the eemr-tube method. I to Cho. 1993; 28: 153-159.
40. Gordis L, editor. Epidemiology. 4th ed. Philadelphia: Saunders Elsevier; 2009.
41. Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer. 1998; 83: 220-231.
42. Roth MJ, Liu SF, Dawsey SM, Zhou B, Copeland C, Wang G-Q, et al. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer. 1997; 80: 2047-2059.
43. Chung CS, Lee YC, Wang CP, Ko JY, Wang WL, Wu MS, et al. Secondary prevention of esophageal squamous cell carcinoma in areas where smoking, alcohol, and betel quid chewing are prevalent. J Formos Med Assoc. 2010; 109: 408-421.
44. Roshandel G, Semnani S, Malekzadeh R. Non-endoscopic screening for esophageal squamous cell carcinoma-a review. MEJDD. 2012; 4: 111-124.
45. Schiller W. Early diagnosis of carcinoma of the cervix. Surg Gynecol Obstet. 1933; 59: 210-222.
46. Voegeli R. Die schillersche jodprobe im rahmen der ösophagusdiagnostik. ORL. 1966; 28: 230-239.
47. Nothmann BJ, Wright JR, Schuster MM. In vivo vital staining as an aid to identification of esophagogastric mucosal junction in man. Dig Dis Sci. 1972; 17: 919-924.
48. Toriie S, Kohli Y, Akasaka Y, Kawai K. New trial for endoscopical observation of esophagus by dye scattering method ein neuer anlauf zur anfärbung der ösophagusmukosa während der endoskopie. Endoscopy. 1975; 7: 75-79.
49. Brodmerkel G. Schiller's test: an aid in esophagoscopic diagnosis. Gastroenterology. 1971; 6: 813.
50. Mori M, Adachi Y, Matsushima T, Matsuda H, Kuwano H, Sugimachi K. Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol. 1993; 88: 701-705.
51. Miyazaki S, Kawahara K, Watanabe S, Hirata M, Iida Y, Okita K, et al. Fundamental studies on Lugol staining method of esophageal carcinomas. Gastroenterol Endosc. 1981; 23: 503-513.
52. Endo M, Ide H. Endoscopic staining in early diagnosis of esophageal cancer: Japan Scientific Societies Press; 1991.
53. Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y, Kato H, et al. Epidermization in the esophageal mucosa: Unusual epithelial changes clearly detected by Lugol's staining. Am J Surg Pathol. 1997; 21: 605-609.
54. Mandard AM, Tourneux J, Gignoux M, Blanc L, Segol P, Mandard JC. In situ carcinoma of the esophagus. Macroscopic study with particular reference to the Lugol test. Endoscopy. 1980; 12: 51-57.
55. Chen LQ, Hu CY, Ghadirian P, Duranceau A. Early detection of esophageal squamous cell carcinoma and its effects on therapy: an overview. Dis Esophagus. 1999; 12: 161-167.
56. Chisholm EM, Williams SR, Leung JW, Chung SC, van Hasselt CA, Li AK. Lugol's iodine dye-enhanced endoscopy in patients with cancer of the oesophagus and head and neck. Eur J Surg Oncol. 1992; 18: 550-552.
57. Ina H, Shibuya H, Ohashi I, Kitagawa M. The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy. Cancer. 1994; 73: 2038-2041.
58. Meyer V, Burtin P, Bour B, Blanchi A, Cales P, Oberti F, et al. Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest Endosc. 1997; 45: 480-484.
59. Misumi A, Harada K, Murakami A, Arima K, Kondo H, Akagi M, et al. Role of Lugol dye endoscopy in the diagnosis of early esophageal cancer. Endoscopy. 1990; 22: 12-16.
60. Shimizu Y Tukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Endoscopic screening for early esophageal cancer by iodine staining in patients with other current or prior primary cancers. Gastrointest Endosc. 2001; 53: 1-5.
61. Shiozaki H, Tahara H, Kobayashi K, Yano H, Tamura S, Imamoto H, et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer. 1990; 66: 2068-2071.
62. Sugimachi K, Kitamura K, Baba K, Ikebe M, Kuwano H. Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution. Gastrointest Endosc. 1992; 38: 657-661.
63. Freitag CP, Barros SG, Kruel CD, Putten AC, Dietz J, Gruber AC, et al. Esophageal dysplasias are detected by endoscopy with Lugol in patients at risk for squamous cell carcinoma in southern Brazil. Dis Esophagus. 1999; 12: 191-195.
64. Hashimoto CL, Iriya K, Baba ER, Navarro-Rodriguez T, Zerbini MC, Eisig JN, et al. Lugol's dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol. 2005; 100: 275-282.
65. Makuuchi H, Machimura T, Shimada H, Mizutani K, Chino O, Kise Y et al. Endoscopic screening for esophageal cancer in 788 patients with head and neck cancers. Tokai JExp ClinMed. 1996; 21: 139-145.
66. Dubuc J, Legoux JL, Winnock M, Seyrig JA, Barbier JP, Barrioz T, et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy. 2006; 38: 690-695.
67. Moschler O, Spahn TW, Middelberg-Bisping C, Grosse-Thie W, Christoph B, Kloeppel G, et al. Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer. Digestion. 2006; 73: 160-166.
68. Tincani AJ, Brandalise N, Altemani A, Scanavini RC, Valerio JB, Lage HT, et al. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% Lugol dye solution in patients with head and neck cancer. HeadNeck. 2000; 22: 170-174.
69. Scherubl H, Lampe BV, Faiss S, Daubler P, Bohlmann P, Plath T, et al. Screening for oesophageal neoplasia in patients with head and neck cancer. Br J Cancer. 2002; 86: 239-243.
70. Yokoyama A, Ohmori T, Makuuchi H, Maruyama K, Okuyama K, Takahashi H, et al. Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer. 1995; 76: 928-934.
71. Ban S, Toyonaga A, Harada H, Ikejiri N, Tanikawa K. Iodine staining for early endoscopic detection of esophageal cancer in alcoholics. Endoscopy. 1998; 30: 253-257.
72. Fagundes R, De Barros S, Pütten A, Mello E, Wagner M, Bassi L, et al. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus. Endoscopy. 1999; 31: 281-285.
73. Nabeya K, Hanaoka T, Onozawa K, Ri S, Nyumura T, Kaku C. Early diagnosis of esophageal cancer. Hepatogastroenterology. 1990; 37: 368-370.
74. Kuwano H, Kitamura K, Baba K, Morita M, Matsuda H, Mori M, et al. Determination of the resection line in early esophageal cancer using intraoperative endoscopic examination with Lugol staining. J Surg Oncol. 1992; 50: 149-152.
75. Pan QJ, Roth MJ, Guo HQ, Kochman ML, Wang GQ, Henry M, et al. Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Linxian, China. Acta Oncologica. 2008; 52: 14-23.
76. Kondo H, Fukuda H, Ono H. Sodium thiosulfate solution spray for relief of irritation caused by Lugol's stain in chromoendoscopy. Gastrointest Endosc. 2001; 53: 199-202.
77. Ishihara R, Yamada T, Iishi H, Kato M, Yamamoto S, Yamamoto S, et al. Quantitative analysis of the color change after iodine staining for diagnosing esophageal high-grade intraepithelial neoplasia and invasive cancer. Gastrointest Endosc. 2009; 69: 213-218.
78. Tajiri H, Matsuda K, Fujisaki J. What can we see with the endoscope? Present status and future perspectives. Digestive Endoscopy. 2002; 14: 131-137.
79. Kara MA, Peters FP, Rosmolen WD, Krishnadath KK, Ten Kate FJ, Fockens P, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: A prospective randomized crossover study. Endoscopy. 2005; 37: 929-936.
80. Gheorghe C. Narrow-band imaging endoscopy for diagnosis of malignant and premalignant gastrointestinal lesions. J Gastrointestin Liver Dis. 2006; 15: 77.
81. Lee Y-C, Wang C-P, Chen C-C, Chiu H-M, Ko J-Y, Lou P-J, et al. Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video). Gastrointest Endosc. 2009; 69: 408-417.
82. Takenaka R, Kawahara Y, Okada H, Hori K, Inoue M, Kawano S, et al. Narrow-band imaging provides reliable screening for esophageal malignancy in patients with head and neck cancers. Am J Gastroenterol. 2009; 104: 2942-2948.
83. Lecleire S, Antonietti M, Iwanicki-Caron I, Duclos A, Lemoine F, Pessot FL, et al. Lugol chromoendoscopy versus narrow-band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study. Dis Esophagus. 2011; 24:418-422.
84. Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow-band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010; 28: 1566-1572.
85. Ishihara R, Inoue T, Uedo N, Yamamoto S, Kawada N, Tsujii Y, et al. Significance of each narrow-band imaging finding in diagnosing squamous mucosal high-grade neoplasia of the esophagus. J Gastroenterol Hepatol. 2010; 25: 1410-1415.
86. Ishihara R, Takeuchi Y, Chatani R, Kidu T, Inoue T, Hanaoka N, et al. Original article: Prospective evaluation of narrow-band imaging endoscopy for screening of esophageal squamous mucosal high-grade neoplasia in experienced and less experienced endoscopists. Dis Esophagus. 2010; 23: 480-486.
87. Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE. Narrowband imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc. 2004; 59: 288-295.
88. Goda K, Tajiri H, Ikegami M, Yoshida Y, Yoshimura N, Kato M, et al. Magnifying endoscopy with narrow-band imaging for predicting the invasion depth of superficial esophageal squamous cell carcinoma. Dis Esophagus. 2009; 22: 453-460.
89. Kawahara Y, Uedo N, Fujishiro M, Goda K, Hirasawa D, Lee JH, et al. The usefulness of NBI magnification on diagnosis of superficial esophageal squamous cell carcinoma. Dig Endosc. 2011; 23: 79-82.
90. Kwon RS, Sahani DV, Brugge WR. Gastrointestinal cancer imaging: Deeper than the eye can see. Gastroenterology. 2005; 128: 1538-1553.
91. Liu H, Li YQ, Yu T, Zhao YA, Zhang JP, Zuo XL, et al. Confocal laser endomicroscopy for superficial esophageal squamous cell carcinoma. Endoscopy. 2009; 41: 99-106.
92. Tomizawa Y, Abdulla HM, Prasad GA, Wong Kee Song L-M, Lutzke LS, Borkenhagen LS, et al. Endocytoscopy in esophageal cancer. Gastrointest Endosc Clin N Am. 2009; 19: 273-281.
93. Kumagai Y, Monma K, Kawada K. Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system. Endoscopy. 2004; 36: 590-594.
94. Fujishiro M, Takubo K, Sato Y, Kaise M, Niwa Y, Kato M, et al. Potential and present limitation of endocytoscopy in the diagnosis of esophageal squamous-cell carcinoma: A multicenter ex vivo pilot study. Gastrointest Endosc. 2007; 66: 551-555.
95. Kumagai Y, Kawada K, Yamazaki S, Iida M, Ochiai T, Momma K, et al. Endocytoscopic observation of esophageal squamous cell carcinoma. Digestive Endoscopy. 2010; 22: 10-16.
96. Polglase AL, Mclaren WJ, Skinner SA, Kiesslich R, Neurath MF, Delaney PM. A fluorescence confocal endomicroscope for in vivo microscopy of the upper-and the lower-GI tract. Gastrointest Endosc. 2005; 62: 686-695.
97. Uedo N, Iishi H, Tatsuta M, Yamada T, Ogiyama H, Imanaka K, et al. A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers. Gastrointest Endosc. 2005; 62: 521-528.
98. Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma-precursor lesions and early diagnosis. World J Gastrointest Endosc. 2012; 4: 9-16.
99. Kara MA, Smits ME, Rosmolen WD, Bultje AC, Ten Kate FJ, Fockens P, et al. A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett's esophagus. Gastrointest Endosc. 2005; 61: 671-678.
100. Wolfsen HC, Crook JE, Krishna M, Achem SR, Devault KR, Bouras EP, et al. Prospective, controlled tandem endoscopy study of narrow-band imaging for dysplasia detection in Barrett's esophagus. Gastroenterology. 2008; 135: 24-31.
101. Curvers W, Fockens P, Bergman J, Singh R, Ragunath K, Wong Kee Song L, et al. Endoscopic trimodal imaging improves the detection of high-grade dysplasia (HGD) and early cancer (EC) in Barrett's esophagus: an international multicenter study. Gastroenterology. 2007; 132: 2586-2586.
102. Poneros JM, Nishioka NS. Diagnosis of Barrett's esophagus using optical coherence tomography. Gastrointest Endosc Clin N Am. 2003; 13: 309.
103. Testoni PA, Mangiavillano B. Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. World J Gastroenterol. 2008; 14: 6444-6452.
104. Lovat LB, Johnson K, Mackenzie GD, Clark BR, Novelli MR, Davies S, et al. Elastic scattering spectroscopy accurately detects high-grade dysplasia and cancer in Barrett's oesophagus. Gut. 2006; 55: 1078-1083.